Interestingly, subjects with familial partial lipodystrophy type 3, a disease linked to pathogenic variants in PPARG, have striking clinical similarity to our proband with IMPA [66, 67]. This evidence concerns the gene PPARG and PPARG-related familial partial lipodystrophy.